ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.22
0.03%
US Tech 100
19,287.60
-0.24%
S&P 500
5,702.55
-0.19%
US Dollar vs CAD
1.35775
0.00%
Bitcoin
63,095.64
-0.44%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) News

ACET

Adicet Bio (ACET)

Adicet Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACET
DateTimeSourceHeadlineSymbolCompany
09/19/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
09/19/20246:00AMBusiness WireADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid TissueNASDAQ:ACETAdicet Bio Inc
09/10/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
08/30/20244:44PMBusiness WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
08/27/20243:00PMBusiness WireAdicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ACETAdicet Bio Inc
08/23/20243:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
08/23/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
08/23/20243:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
08/20/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
08/20/20243:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
08/19/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
08/19/20246:00AMBusiness WireAdicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of DirectorsNASDAQ:ACETAdicet Bio Inc
08/13/20246:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACETAdicet Bio Inc
08/13/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
08/13/20246:00AMBusiness WireAdicet Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:ACETAdicet Bio Inc
08/01/20243:00PMBusiness WireAdicet Bio to Participate in Upcoming Investor ConferencesNASDAQ:ACETAdicet Bio Inc
07/31/20244:25PMBusiness WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
07/08/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
07/08/20246:00AMBusiness WireAdicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell CarcinomaNASDAQ:ACETAdicet Bio Inc
06/28/20244:00PMBusiness WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
06/24/20246:00AMBusiness WireAdicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell CarcinomaNASDAQ:ACETAdicet Bio Inc
06/07/20243:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
06/07/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
06/07/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
06/07/20243:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
06/07/20243:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACETAdicet Bio Inc
06/07/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
06/05/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACETAdicet Bio Inc
06/05/20246:00AMBusiness WireAdicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus NephritisNASDAQ:ACETAdicet Bio Inc
05/31/20244:41PMBusiness WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACETAdicet Bio Inc
 Showing the most relevant articles for your search:NASDAQ:ACET

Your Recent History

NASDAQ
AMRN
Amarin
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
NB
NioCorp Developments
USOTC
MONI
Moon Equity (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NYSE
GME
GameStop
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
COOP
Mr Cooper
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
RDGL
Vivos (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved